Zueter, Abdel Rahman Mohammad Abdallah
(2016)
Clinical characteristics, genotyping and molecular detection of burkholderia pseudomallei.
PhD thesis, Universiti Sains Malaysia.
Abstract
Burkholderia pseudomallei is a saprophytic Gram-negative bacterium that infects
human body through inhalation, ingestion or percutaneous inoculation and causes
melioidosis. The pathophysiology and clinical presentations of melioidosis are
influenced by B. pseudomallei load on exposure, route of infection and human risk
factors. Laboratory methods for B. pseudomallei include various procedures applied
for diagnosis, molecular epidemiology and pathogenicity studies using conventional,
immunological and molecular techniques.
In this study, the clinical characteristics and risk factors of melioidosis were
explored. Genotyping using multilocus sequence typing (MLST) was performed on
clinical B. pseudomallei isolates to explore the degree of their genotypic diversity in
the area of the study and to correlate the identified genotypes with clinical
presentations and outcomes. In order to improve the laboratory detection of B.
pseudomallei, a PCR-based assay targeting sctq gene of the TTS1 cluster has been
developed.
In this study, which involved 158 cases, the principal clinical presentations reported
were lung infection in 65 (41.1%), skin infection in 44 (27.8%), septic
arthritis/osteomyelitis in 20 (12.7%) and liver infection in 19 (12.0%). Bacteremic
melioidosis was seen in most cases (n=121, 76.6%). Focal melioidosis was seen in124 (78.5%) of patients and multi-focal melioidosis was reported in 45 (28.5%)
cases, while melioidosis with no evident focus was reported in 34 (21.5%) patients.
Internal organ abscesses and secondary foci in lungs and/or soft tissue were common
in this study. Sixty seven (41%) patients were admitted during the monsoonal wet
season. Death due to melioidosis was reported in 52 (32.9%) of patients, while
recurrent infections occurred in 4 (2.5%) patients. Twelve fatal melioidosis cases
directly attributed to the absence of prompt acute-phase treatment were seen in this
study. Predisposing risk factors were reported in 133(84.2%) patients, which
included diabetes (74.7%), immune disturbances (9.5%), cancer (4.4%) and chronic
kidney disease (11.4%). On multivariate analysis, the independent predictors of
mortality were the presence of at least one co-morbid factor (OR 3.0; 95% CI 1.1–
8.4), the occurrence of septic shock (OR 16.5; 95% CI 6.1–44.9) and age >40 years
(OR 6.47; 95% CI 1.7–23.8).
Multilocus sequence typing of 83 B. pseudomallei isolates has revealed 32 different
sequence types, of which 13 (40%) were novel, namely: ST1317, ST1318, ST1319,
ST1320, ST1321, ST1322, ST1323, ST1324, ST1325, ST1326, ST1327, ST1358 and
ST1359. All retrieved sequence types were deposited in MLST database. The
frequencies of sequence types among the 83 isolates ranged from 1-12 observations
with predomination of ST54, ST371 and ST289. All non-novel sequence types
identified in this study were not exclusive for Malaysia; they were identified in other
regional countries with different frequencies. However, some of these sequence types
were firstly identified in Malaysia such as ST371, ST164, ST47, ST306, ST55,
ST376, ST402, ST507, ST368, ST369, ST10 and ST168.
This study has provided major review for melioidosis and its causative agent,
Burkholderia pseudomallei among selected population clusters residing in the
Northeastern part of Peninsular Malaysia. Clinical presentations and risk factors of
melioidosis were not unique for Malaysia and B. pseudomallei genotypes showed
wide diversity that was correlated with the distribution of different strains in the
environment. Novel sequence types indicated the genetic activity and instability of
the bacteria which predicted the emergence of new strains that may harbor different
virulence effect. This work kept on previous assumption that host and environmental
factors were behind the diversity for clinical presentation of the disease. For
molecular diagnosis, further upgrading and evaluation are needed to improve the
performance of the assay.
Actions (login required)
![View Item View Item](/style/images/action_view.png) |
View Item |